Ledger.Open graph →
SEC Form D · filed September 30, 2022

Diceros Therapeutics, Inc

Offering
$16.7M
Sold
$6.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Stephen R. Seiler · Newton, MAExec · DirectorJonathan R. Fleming · Newton, MADirectorNelson E. Lamis · Aventura, FLExec · DirectorParis Malde · Camana Bay, Grand Cayman, Cayman IslandsDirectorEyal I. Wagner · Gibraltar, J1DirectorThomas Warman · Wilmington, DEExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗